Hansa Biopharma AB
STO:HNSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hansa Biopharma AB
STO:HNSA
|
SE |
|
Dupont De Nemours Inc
NYSE:DD
|
US |
|
G
|
Geely Automobile Holdings Ltd
OTC:GELYY
|
HK |
|
360 DigiTech Inc
NASDAQ:QFIN
|
CN |
|
G
|
Gap Inc
BMV:GPS
|
US |
|
Canfor Corp
TSX:CFP
|
CA |
|
H
|
Humm Group Ltd
F:F5L
|
AU |
|
NOW Inc
NYSE:DNOW
|
US |
|
China Resources Land Ltd
OTC:CRBJF
|
HK |
|
Groupe SFPI SA
PAR:SFPI
|
FR |
|
Benitec Biopharma Inc
NASDAQ:BNTC
|
US |
|
ID Logistics SAS
PAR:IDL
|
FR |
Intrinsic Value
The intrinsic value for Hansa Biopharma AB (HNSA) under the Base Case is hidden
SEK.
Compared with the current market price of 30.84 SEK, the stock appears hidden
.
HNSA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether HNSA usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Hansa Biopharma AB.
Fundamental Analysis
Revenue & Expenses Breakdown
Hansa Biopharma AB
Earnings Waterfall
Hansa Biopharma AB
The intrinsic value for Hansa Biopharma AB (HNSA) under the Base Case is hidden SEK.
Compared with the current market price of 30.84 SEK, the stock appears hidden.
